Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism
- 18 September 2017
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (40) , 10725-10730
Abstract
Significance: Metastasis formation from malignant tumors is the leading cause of cancer-related deaths. There is an increasing body of evidence indicating that immune cells in distant organs actively contribute to this process by establishing a tissue environment that is hospitable for cancer cells. In this study, we show that deletion of retinoid X receptor (RXR), a cellular sensor of vitamin A metabolites, specifically in the myeloid lineage of the immune system, leads to an enhanced metastasis rate. We also demonstrate that RXR inhibits the expression of a number of genes that encode proteins involved in the promotion of metastasis formation. Surprisingly, our results suggest that this activity of RXR is independent of the presence of its activators.Keywords
Funding Information
- NR-NET (PITN-GA-2013-606806)
- Hungarian Scientific Research Fund (OTKA K100196, K111941 and K116855)
- American Heart Association (17POST33660450)
This publication has 33 references indexed in Scilit:
- Characteristics and Significance of the Pre-metastatic NicheCancer Cell, 2016
- The Bcl6-SMRT/NCoR Cistrome Represses Inflammation to Attenuate AtherosclerosisCell Metabolism, 2012
- Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial TransitionCancer Research, 2012
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandNature, 2011
- Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic UtilityPLOS ONE, 2011
- Differential Action on Coregulator Interaction Defines Inverse Retinoid Agonists and Neutral AntagonistsChemistry & Biology, 2009
- Loss of Trim24 (Tif1α) gene function confers oncogenic activity to retinoic acid receptor alphaNature Genetics, 2007
- Design of selective nuclear receptor modulators: RAR and RXR as a case studyNature Reviews Drug Discovery, 2007
- Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.2003
- The promise of retinoids to fight against cancerNature Reviews Cancer, 2001